Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Aug 22, 2024 5:43pm
229 Views
Post# 36192599

RE:With the expiring warrants gone

RE:With the expiring warrants gone57 million warrants expired.  I think total float fully diluted is around 275 Million instead of 330 million.  That's close to 20% decrease.  It will be brought back up to about same level after further dilution and should be enough to get us to BTD and beyond IMHO.  If they raise 5$ million plus another $7.5 million in new warrants and about 8 million in 25 and 35. Ent warrants, they could end up with another $20 million at around 325 million shares fully diluted.  That takes us to full approval and PH1 for GBM NSCLC and PH1 Avian Flu..  IMHO

Oden6570 wrote: Would this not in theory make remaining shares more valuable  ? The float is now substantially lowered , this must mean something to share value IMHO.


<< Previous
Bullboard Posts
Next >>